Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomised, double-blind, placebo-controlled clinical trial

Anti-obesity effects of Yerba Mate

(Ilex Paraguariensis): a randomised, double-blind,
placebo-controlled clinical trial

The content on this page comes from National Library of Medicine, and has been translated into Polish.

Link to source – https://pubmed.ncbi.nlm.nih.gov/26408319/

Abstract

Introduction: Obesity is a serious health problem. Field research on food that has recently attracted great interest concerns the potential of natural products in combating obesity. Yerba Mate may be helpful in reducing body weight and body fat. The aim of this study was to investigate the efficacy and safety of Yerba Mate supplementation in obese Koreans.

Methods: A randomized, double-blind, placebo-controlled trial was conducted. Individuals with obesity (body mass index (BMI) ≥ 25 but < 35 kg/m2 and waist-to-hip ratio (WHR) ≥ 0.90 for men and ≥ 0.85 for women) received either oral Yerba Mate capsule supplements (n = 15) or placebo (n = 15) for 12 weeks. Subjects took three capsules with each meal, three times a day in total (3 g/day). Measured outcomes included efficacy (abdominal fat tissue distribution, anthropometric parameters and blood lipid profiles) and safety (adverse events, laboratory test results and vital signs).

Results: Over 12 weeks of Yerba Mate supplementation, decreases in fat mass (P = 0.036) and percentage body fat (P = 0.030) compared to the placebo group were statistically significant. WHR was significantly reduced (P = 0.004) in the Yerba Mate group compared to the placebo group. No clinically significant changes in safety parameters were observed.

Conclusions: Yerba Mate supplementation reduced fat mass, percentage body fat and WHR. Yerba Mate was a potent anti-obesity agent that did not cause significant side effects. These results suggest that Yerba Mate supplementation may be effective in treating obese individuals.

Trial registration: ClinicalTrials.gov: ( NCT01778257 ).

Figures

Fig. 1
Fig. 2

The content on this page comes from National Library of Medicine, and has been translated into Polish.

Link to source – https://pubmed.ncbi.nlm.nih.gov/26408319/